Development Level

Tbio 2 | 10,625
Tclin 2 | 602
Tchem 1 | 1,890

IMPC Term

decreased CD5-positive Ly6C-po... 1 | 4
decreased KLRG1+ CD8 alpha bet... 1 | 8
decreased Ly6C low monocyte nu... 1 | 23
decreased monocyte cell number 1 | 28
increased B cell number 1 | 23
increased NK cell number 1 | 19
increased mature B cell number 1 | 12
preweaning lethality, incomple... 1 | 260

Disease

Cancer 4 | 2,346
Anemia 3 | 252
Hypersensitivity reaction type II disease 3 | 235
Influenza 3 | 142
Multiple Sclerosis 3 | 498
Thrombocytopenia 3 | 105
Acquired immunodeficiency syndrome 2 | 164
Hepatitis B 2 | 103
Hepatitis C 2 | 90
Kidney disease 2 | 396
Leukopenia 2 | 42
Skin disease 2 | 65
osteosarcoma 2 | 7,933
psoriasis 2 | 6,685
Adenoid hypertrophy 1 | 4
Agammaglobulinemia 1 | 24
Aicardi-Goutieres syndrome 1 | 18
Allergic hypersensitivity disease 1 | 123
Anogenital venereal wart 1 | 8
Antibody Deficiency due to Defect in CD19 1 | 1
Bone disease 1 | 6
Chronic hepatitis C 1 | 12
Chronic type B viral hepatitis 1 | 2
Collagen disease 1 | 25
Common variable immunodeficiency 1 | 72
Connective tissue disease 1 | 59
Cryoglobulinemia 1 | 15
Dementia 1 | 129
Diarrhea 1 | 155
Down syndrome 1 | 548
Encephalitis 1 | 54
GAUCHER DISEASE, PERINATAL LETHAL 1 | 1
Gallbladder adenocarcinoma 1 | 1
Gastrointestinal system disease 1 | 50
Gaucher Disease 1 | 4
Gaucher Disease, Type 1 1 | 2
Gaucher Disease, Type 2 (disorder) 1 | 1
Gaucher Disease, Type 3 (disorder) 1 | 1
Gaucher Disease, Type Iiic 1 | 1
Gaucher's disease 1 | 24
Gaucher-like disease 1 | 1
Hepatitis 1 | 61
Herpes simplex 1 | 19
Hypothyroidism 1 | 89
Lewy Body Disease 1 | 19
Liver Cirrhosis 1 | 101
Liver disease 1 | 219
Lung disease 1 | 132
Lymphatic system disease 1 | 14
Lymphoma 1 | 56
Macroglobulinemia 1 | 17
Muscle Weakness 1 | 92
Neurodegenerative disease 1 | 383
Neuromyelitis optica 1 | 20
PARKINSON DISEASE, LATE-ONSET 1 | 18
Parkinson Disease 1 | 102
Parkinson's disease 1 | 364
Polycythemia Vera 1 | 24
Postencephalitic Parkinson disease 1 | 1
Pre B-cell acute lymphoblastic leukemia 1 | 4
Pulmonary hypertension 1 | 52
Relapsing remitting multiple sclerosis 1 | 14
Rheumatoid Arthritis 1 | 1,160
Septicemic plague 1 | 3
Severe Combined Immunodeficiency 1 | 46
Severe acute respiratory syndrome 1 | 26
Stomatitis 1 | 19
Subacute sclerosing panencephalitis 1 | 10
Tetanus 1 | 66
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Vasculitis 1 | 64
Virus Diseases 1 | 2
diabetes mellitus 1 | 1,663
hepatocellular carcinoma 1 | 532
interstitial cystitis 1 | 2,299
medulloblastoma, large-cell 1 | 6,234
nasopharyngeal carcinoma 1 | 1,056
ovarian cancer 1 | 8,484
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
periodontitis 1 | 269
primary Sjogren syndrome 1 | 789
tuberculosis and treatment for 3 months 1 | 327
tuberculosis and treatment for 6 months 1 | 686
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 5 | 17,995
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444
Cardiovascular System 4 | 17,958
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

5S06GM008241-20 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interferon alpha-1/13 IFNA13 Tbio Non-IDG -3.85630 7619.4 379
B-lymphocyte antigen CD19 CD19 Tclin Non-IDG -3.43057 3029.8 2072
Glucosylceramidase GBA Tchem Enzyme -3.16115 1484.2 216
Galectin-7 LGALS7B Tbio Non-IDG -2.78890 603.4 113
Interferon alpha/beta receptor 1 IFNAR1 Tclin Non-IDG -2.57929 407.4 484